Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- Check6 days agoChange DetectedFDA-regulated drug and device indicators were added to the study record, along with an expanded set of MeSH terms and updated metadata such as study dates and enrollment. The previous error-page content was removed, and the page now displays the standard ClinicalTrials.gov study details for this trial.SummaryDifference43%

- Check13 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a backend or formatting update to the ClinicalTrials.gov page rather than a substantive change to the study content.SummaryDifference16%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a software update. No study details or content appear to be affected.SummaryDifference0.1%

- Check49 days agoChange DetectedPage revision tag updated from v3.6.2 to v3.6.3, signaling a new build of the ClinicalTrials.gov page. This update does not appear to alter the study details or user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, signaling a minor update to the page or its underlying system rather than a change to the study details.SummaryDifference0.1%

- Check70 days agoChange DetectedRecruitment status on the study page is updated to indicate no longer looking for participants, signaling that enrollment has ended. New guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and the page revision label was updated to v3.6.0 (replacing the previous v3.5.5).SummaryDifference0.6%

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.